CORPORATE PRESENTATION
We invite you to download our corporate presentation to help understand our unique purpose, our current commercial footprint, and our innovative pipeline.
Quarterly Results
Press Releases
12 May 2026
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond,Chief Financial Officer and Treasurer, will provide a company...
Presentations of results from the positive TETON phase 3 pivotal studies of inhaled treprostinil in idiopathic pulmonary fibrosis (IPF) include efficacy and safety results from TETON-1 and integrated results from TETON-1...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31,...
Professor Dwek’s term as a director will conclude at the 2026 Annual Meeting of ShareholdersSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR), a...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2026 financial results in a press release that...
An interim analysis of the PHINDER study identifies non-invasive measures that may facilitate earlier detection and management of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD)An interim...
Events and presentations
19 May 2026
RBC Capital Markets Global Healthcare Conference
09:30 AM ET
06 May 2026
United Therapeutics First Quarter 2026 Financial Results
09:00 AM ET
09 Mar 2026
Leerink Global Healthcare Conference
01:00 PM ET
02 Mar 2026
TD Cowen Health Care Conference
02:30 PM ET
02 Mar 2026
Phase 3 ADVANCE OUTCOMES Clinical Trial Results
08:30 AM ET
25 Feb 2026
United Therapeutics Fourth Quarter and Full Year 2025 Financial Results
09:00 AM ET